Category:Michael E. Jung of Los Angeles CA (US)

From WikiPatents
Jump to navigation Jump to search

Michael E. Jung of Los Angeles CA (US)

Executive Summary

Michael E. Jung of Los Angeles CA (US) is an inventor who has filed 6 patents. Their primary areas of innovation include Antineoplastic agents (3 patents), SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (2 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), and they have worked with companies such as The Regents of the University of California (6 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

Michael E. Jung of Los Angeles CA (US) Monthly Patent Applications.png

Technology Areas

Michael E. Jung of Los Angeles CA (US) Top Technology Areas.png

List of Technology Areas

  • A61P35/00 (Antineoplastic agents): 3 patents
  • A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 2 patents
  • A61K31/519 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
  • A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 2 patents
  • C07D491/056 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 2 patents
  • C07C237/04 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 2 patents
  • C07D213/40 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 2 patents
  • C07D275/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D213/74 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D217/22 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D239/42 (One nitrogen atom (nitro radicals): 1 patents
  • C07D239/94 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D261/20 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D417/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D417/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D513/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • A61K31/5377 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K31/551 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • C07D519/00 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • G01N33/66 (involving blood sugars, e.g. galactose): 1 patents
  • C07B2200/05 (GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation): 1 patents
  • G01N2800/52 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms): 1 patents
  • C07D213/68 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D213/38 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07C235/62 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07C311/07 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07D211/86 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D213/89 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D295/088 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D295/15 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D401/06 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D401/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D405/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D409/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07C237/38 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07D213/50 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D213/55 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D213/06 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07C229/08 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07D223/16 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D233/32 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07C237/06 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07D209/48 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D223/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D211/60 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D207/16 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D207/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07C237/20 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07D213/30 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D211/50 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07C2602/10 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07C2601/08 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07B2200/07 (GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation): 1 patents
  • C07C2601/04 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07C2601/14 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07C2602/08 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • C07D471/04 (Ortho-condensed systems): 1 patents
  • A61P17/14 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61K9/0014 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
  • C07F9/535 (ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins): 1 patents
  • C07D413/06 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D417/06 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D209/22 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • C07D239/95 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • A61K31/40 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K31/496 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K31/517 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • C07D405/10 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
  • G01N33/5011 ({for testing antineoplastic activity}): 1 patents
  • G01N33/57407 ({Specifically defined cancers}): 1 patents

Companies

Michael E. Jung of Los Angeles CA (US) Top Companies.png

List of Companies

  • The Regents of the University of California: 6 patents

Collaborators